National Assessment of Warfarin Anticoagulation Therapy for Stroke Prevention in Atrial Fibrillation

BACKGROUND—Anticoagulation control with warfarin, as assessed by the international normalized ratio (INR), is challenging. Time in the therapeutic range has been inversely correlated with major hemorrhage, thrombosis, and mortality. Quest Diagnostics offers standardized INR laboratory testing servic...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Circulation (New York, N.Y.) N.Y.), 2014-04, Vol.129 (13), p.1407-1414
Hauptverfasser:	Dlott, Jeffrey S, George, Roberta A, Huang, Xiaohua, Odeh, Mouneer, Kaufman, Harvey W, Ansell, Jack, Hylek, Elaine M
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Anticoagulants - therapeutic use Atrial Fibrillation - complications Atrial Fibrillation - epidemiology Biological and medical sciences Blood and lymphatic vessels Blood. Blood coagulation. Reticuloendothelial system Cardiac dysrhythmias Cardiology. Vascular system Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous Female Follow-Up Studies Heart Humans International Normalized Ratio Male Medical sciences Middle Aged Neurology Pharmacology. Drug treatments Regression Analysis Retrospective Studies Risk Assessment Risk Factors Stroke - epidemiology Stroke - prevention & control Time Factors Treatment Outcome United States - epidemiology Vascular diseases and vascular malformations of the nervous system Warfarin - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!